Skip to content
PubMed This is a summary of 92 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 92 referenced papers

Top Authors

Felice Petraglia
University of Modena and Reggio Emilia
Sun‐Wei Guo
Obstetrics and Gynecology Hospital of Fudan University
Stacey A. Missmer
Harvard University
Silvia Vannuccini
European Society for Sexual Medicine
Marie‐Madeleine Dolmans
Cliniques Universitaires Saint-Luc
Malcolm G. Munro
University of California, Los Angeles
Hisao Osada
Osaka Nishi Clinic
Margit Dueholm
Aarhus University Hospital

Top Institutions

Ranked by publications Top 10 institutions
04

Obstetrics and Gynecology Hospital of Fudan University

Shanghai, China

97 papers
05

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

59 papers
10

References

References (92)
  1. 1

    Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition.

    Struble J, Reid S, Bedaiwy MA

    Journal of minimally invasive gynecology 2016; (23(2)):164-85.

    PMID: 26427702
  2. 2

    Comparison of classic terminology with the FIGO PALM-COEIN system for classification of the underlying causes of abnormal uterine bleeding.

    Töz E, Sancı M, Özcan A, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2016; (133(3)):325-8.

    PMID: 26952349
  3. 3

    The Significance of MRI Evaluation of the Uterine Junctional Zone in the Early Diagnosis of Adenomyosis.

    Sofic A, Husic-Selimovic A, Carovac A, et al.

    Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH 2016; (24(2)):103-6 doi:10.5455/aim.2016.24.103-106.

    PMID: 27147800
  4. 4

    Expression of Inflammatory and Neurogenic Mediators in Adenomyosis.

    Carrarelli P, Yen CF, Funghi L, et al.

    Reproductive sciences (Thousand Oaks, Calif.) 2017; (24(3)):369-375 doi:10.1177/1933719116657192.

    PMID: 27440813
  5. 5

    Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease.

    Puente JM, Fabris A, Patel J, et al.

    Reproductive biology and endocrinology : RB&E 2016; (14(1)):60 doi:10.1186/s12958-016-0185-6.

    PMID: 27645154
  6. 6

    Pathogenesis of adenomyosis: an update on molecular mechanisms.

    Vannuccini S, Tosti C, Carmona F, et al.

    Reproductive biomedicine online 2017; (35(5)):592-601 doi:10.1016/j.rbmo.2017.06.016.

    PMID: 28693952
  7. 7

    Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study.

    Xiao-Ying Z, Ying-Shu G, Jiu-Mei C, et al.

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2018; (34(8)):1289-1297 doi:10.1080/02656736.2018.1440014.

    PMID: 29447020
  8. 8

    Endometriosis: clinical features, MR imaging findings and pathologic correlation.

    Foti PV, Farina R, Palmucci S, et al.

    Insights into imaging 2018; (9(2)):149-172 doi:10.1007/s13244-017-0591-0.

    PMID: 29450853
  9. 9

    Introduction: Uterine adenomyosis, another enigmatic disease of our time.

    Donnez J, Donnez O, Dolmans MM

    Fertility and sterility 2018; (109(3)):369-370 doi:10.1016/j.fertnstert.2018.01.035.

    PMID: 29526476
  10. 10

    Uterine adenomyosis and adenomyoma: the surgical approach.

    Osada H

    Fertility and sterility 2018; (109(3)):406-417 doi:10.1016/j.fertnstert.2018.01.032.

    PMID: 29566853
  11. 11

    Sonographic classification and reporting system for diagnosing adenomyosis.

    Van den Bosch T, de Bruijn AM, de Leeuw RA, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019; (53(5)):576-582 doi:10.1002/uog.19096.

    PMID: 29790217
  12. 12

    Long-term dienogest administration in patients with symptomatic adenomyosis.

    Neriishi K, Hirata T, Fukuda S, et al.

    The journal of obstetrics and gynaecology research 2018; (44(8)):1439-1444 doi:10.1111/jog.13674.

    PMID: 29845696
  13. 13

    Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: A cross-sectional study.

    Sun Y, Wang Y, Mao L, et al.

    Medicine 2018; (97(31)):e11457 doi:10.1097/MD.0000000000011457.

    PMID: 30075511
  14. 14

    Two- and three-dimensional ultrasonographic features related to histopathology of the uterine endometrial-myometrial junctional zone.

    Rasmussen CK, Hansen ES, Dueholm M

    Acta obstetricia et gynecologica Scandinavica 2019; (98(2)):205-214 doi:10.1111/aogs.13484.

    PMID: 30317553
  15. 15

    Effects of adenomyosis on obstetric outcomes.

    Cozzolino M, Basile F, Pontrelli G

    Minerva ginecologica 2019; (71(2)):146-154 doi:10.23736/S0026-4784.18.04318-6.

    PMID: 30318871
  16. 16

    A sonographic classification of adenomyosis: interobserver reproducibility in the evaluation of type and degree of the myometrial involvement.

    Lazzeri L, Morosetti G, Centini G, et al.

    Fertility and sterility 2018; (110(6)):1154-1161.e3 doi:10.1016/j.fertnstert.2018.06.031.

    PMID: 30396560
  17. 17

    The rate of euploid miscarriage is increased in the setting of adenomyosis.

    Stanekova V, Woodman RJ, Tremellen K

    Human reproduction open 2018; (2018(3)):hoy011 doi:10.1093/hropen/hoy011.

    PMID: 30895252
  18. 18

    Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy.

    Dessouky R, Gamil SA, Nada MG, et al.

    Insights into imaging 2019; (10(1)):48 doi:10.1186/s13244-019-0732-8.

    PMID: 31030317
  19. 19

    Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis.

    Liang Z, Yin M, Ma M, et al.

    Reproductive biomedicine online 2019; (39(1)):111-118 doi:10.1016/j.rbmo.2019.03.101.

    PMID: 31109894
  20. 20

    Diagnosing adenomyosis with MRI: a prospective study revisiting the junctional zone thickness cutoff of 12 mm as a diagnostic marker.

    Tellum T, Matic GV, Dormagen JB, et al.

    European radiology 2019; (29(12)):6971-6981 doi:10.1007/s00330-019-06308-3.

    PMID: 31264010
  21. 21

    Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution.

    Zhu L, Chen S, Che X, et al.

    Journal of pain research 2019; (12()):1917-1924 doi:10.2147/JPR.S205561.

    PMID: 31303783
  22. 22

    Accuracy of findings in the diagnosis of uterine adenomyosis on ultrasound.

    Sam M, Raubenheimer M, Manolea F, et al.

    Abdominal radiology (New York) 2020; (45(3)):842-850 doi:10.1007/s00261-019-02231-9.

    PMID: 31552462
  23. 23

    Imaging for Adenomyosis: Making the Diagnosis by Sonography.

    Bluhm M, Dueholm M

    Journal of minimally invasive gynecology 2020; (27(2)):267 doi:10.1016/j.jmig.2019.10.001.

    PMID: 31610319
  24. 24

    The Pathogenesis of Adenomyosis vis-à-vis Endometriosis.

    Guo SW

    Journal of clinical medicine 2020; (9(2)) doi:10.3390/jcm9020485.

    PMID: 32050720
  25. 25

    Diagnosing adenomyosis: an integrated clinical and imaging approach.

    Chapron C, Vannuccini S, Santulli P, et al.

    Human reproduction update 2020; (26(3)):392-411 doi:10.1093/humupd/dmz049.

    PMID: 32097456
  26. 26

    Importance of transient myometrial contractions in diagnosis of adenomyosis and congenital uterine anomalies.

    Van den Bosch T, Van Schoubroeck D, Alcazar JL, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2021; (57(4)):651-653 doi:10.1002/uog.22036.

    PMID: 32250499
  27. 27

    Ob/Gyn resident self-perceived preparedness for minimally invasive surgery.

    Klebanoff JS, Marfori CQ, Vargas MV, et al.

    BMC medical education 2020; (20(1)):185 doi:10.1186/s12909-020-02090-9.

    PMID: 32503585
  28. 28

    Essentials in Minimally Invasive Gynecology Manual Skills Construct Validation Trial.

    Munro MG, Advincula AP, Banks EH, et al.

    Obstetrics and gynecology 2020; (136(1)):83-96 doi:10.1097/AOG.0000000000003936.

    PMID: 32541289
  29. 29

    Comparing Surgical Experience and Skill Using a High-Fidelity, Total Laparoscopic Hysterectomy Model.

    Arora C, Menzies A, Han ES, et al.

    Obstetrics and gynecology 2020; (136(1)):97-108 doi:10.1097/AOG.0000000000003897.

    PMID: 32541295
  30. 30

    Adenomyosis as a Potential Risk Factor for Adverse Pregnancy Outcomes: A Multicenter Case-Control Study.

    Shinohara S, Okuda Y, Hirata S, Suzuki K

    The Tohoku journal of experimental medicine 2020; (251(3)):231-239 doi:10.1620/tjem.251.231.

    PMID: 32684535
  31. 31

    Imaging Diagnosis of Adenomyosis.

    O'Shea A, Figueiredo G, Lee SI

    Seminars in reproductive medicine 2020; (38(2-03)):119-128 doi:10.1055/s-0040-1719017.

    PMID: 33197946
  32. 32

    Transvaginal Sonographic Imaging and Associated Techniques for Diagnosis of Ovarian, Deep Endometriosis, and Adenomyosis: A Comprehensive Review.

    Aas-Eng MK, Montanari E, Lieng M, et al.

    Seminars in reproductive medicine 2020; (38(2-03)):216-226 doi:10.1055/s-0040-1718740.

    PMID: 33232986
  33. 33

    Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment.

    Hai N, Hou Q, Guo R

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2021; (38(1)):65-69 doi:10.1080/02656736.2021.1874063.

    PMID: 33472465
  34. 34

    Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study.

    Lan J, Wu Y, Wu Z, et al.

    Frontiers in endocrinology 2021; (12()):609771 doi:10.3389/fendo.2021.609771.

    PMID: 34135858
  35. 35

    The Value of Adenomyosis Type in Clinical Assessment: A Single-center Experience of 755 Nodular and Diffuse Adenomyosis Cases.

    Selvi Demirtas G, Uyar I

    Archives of Iranian medicine 2021; (24(5)):374-382 doi:10.34172/aim.2021.54.

    PMID: 34196202
  36. 36

    Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database.

    Loughlin AM, Chiuve SE, Reznor G, et al.

    Pharmacoepidemiology and drug safety 2021; (30(12)):1675-1686 doi:10.1002/pds.5333.

    PMID: 34292640
  37. 37

    Association of 2D and 3D transvaginal ultrasound findings with adenomyosis in symptomatic women of reproductive age: a prospective study.

    Marques ALS, Andres MP, Mattos LA, et al.

    Clinics (Sao Paulo, Brazil) 2021; (76()):e2981 doi:10.6061/clinics/2021/e2981.

    PMID: 34406269
  38. 38

    Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding.

    Yang H, Wang S, Fu X, et al.

    The journal of obstetrics and gynaecology research 2022; (48(1)):161-168 doi:10.1111/jog.15031.

    PMID: 34672405
  39. 39

    Diagnostic accuracy of clinically reported adenomyosis on pelvic ultrasound and MRI compared to surgical pathology.

    Zanolli NC, Cline BC, Befera NT, Martin JG

    Clinical imaging 2022; (82()):117-120 doi:10.1016/j.clinimag.2021.11.012.

    PMID: 34808582
  40. 40

    Barriers to self-management of patients with adenomyosis: A qualitative study.

    Huang R, Li X, Jiang H, Li Q

    Nursing open 2022; (9(2)):1086-1095 doi:10.1002/nop2.1148.

    PMID: 34859610
  41. 41

    Adenomyosis and fertility: does adenomyosis impact fertility and does treatment improve outcomes.

    French HM, Zhang W, Movilla PR, et al.

    Current opinion in obstetrics & gynecology 2022; (34(4)):227-236 doi:10.1097/GCO.0000000000000789.

    PMID: 35895965
  42. 42

    Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.

    Bianchi P, Guo SW, Habiba M, Benagiano G

    Journal of clinical medicine 2022; (11(19)) doi:10.3390/jcm11195836.

    PMID: 36233703
  43. 43

    Uterine junctional zone and adenomyosis: comparison of MRI, transvaginal ultrasound and histology.

    Harmsen MJ, Trommelen LM, de Leeuw RA, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023; (62(1)):42-60 doi:10.1002/uog.26117.

    PMID: 36370446
  44. 44

    An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.

    Zhang H, Cao B, Tong J, et al.

    BMC women's health 2022; (22(1)):451 doi:10.1186/s12905-022-01932-6.

    PMID: 36384588
  45. 45

    The ADENO study: ADenomyosis and its Effect on Neonatal and Obstetric outcomes: a retrospective population-based study.

    Rees CO, van Vliet H, Siebers A, et al.

    American journal of obstetrics and gynecology 2023; (229(1)):49.e1-49.e12 doi:10.1016/j.ajog.2022.12.013.

    PMID: 36539028
  46. 46

    The effect of adenomyosis types on clinical outcomes of IVF embryo transfer after ultra-long GnRH agonist protocol.

    Han B, Liang T, Zhang W, et al.

    Reproductive biomedicine online 2023; (46(2)):346-351 doi:10.1016/j.rbmo.2022.09.021.

    PMID: 36549997
  47. 47

    Endometrial Inflammation and Impaired Spontaneous Decidualization: Insights into the Pathogenesis of Adenomyosis.

    Kobayashi H

    International journal of environmental research and public health 2023; (20(4)) doi:10.3390/ijerph20043762.

    PMID: 36834456
  48. 48

    Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis.

    Ikebuchi A, Osaki M, Wada I, et al.

    Journal of gynecology obstetrics and human reproduction 2023; (52(9)):102645 doi:10.1016/j.jogoh.2023.102645.

    PMID: 37597576
  49. 49

    Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.

    Guo W, Lin Y, Hu S, Shen Y

    Clinical therapeutics 2023; (45(10)):973-976 doi:10.1016/j.clinthera.2023.07.019.

    PMID: 37599165
  50. 50

    Differences in the incidence of obstetric complications depending on the extent and location of adenomyosis lesions.

    Hashimoto A, Iriyama T, Sayama S, et al.

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2023; (36(2)):2226789 doi:10.1080/14767058.2023.2226789.

    PMID: 37787637
  51. 51

    Pregnancy outcomes of adenomyotic patients with primary infertility after high-intensity focused ultrasound treatment.

    Xiong L, Cheng W, Wang Z, Shi Q

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2023; (40(1)):2264547 doi:10.1080/02656736.2023.2264547.

    PMID: 37903541
  52. 52

    Impact of adenomyosis on in vitro fertilization outcomes in women undergoing donor oocyte transfers: a prospective observational study.

    Cozzolino M, Cosentino M, Loiudice L, et al.

    Fertility and sterility 2024; (121(3)):480-488 doi:10.1016/j.fertnstert.2023.11.034.

    PMID: 38043844
  53. 53

    Endometriosis and adenomyosis: Similarities and differences.

    Donnez J, Stratopoulou CA, Dolmans MM

    Best practice & research. Clinical obstetrics & gynaecology 2024; (92()):102432 doi:10.1016/j.bpobgyn.2023.102432.

    PMID: 38103509
  54. 54

    Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders.

    Juárez-Barber E, Corachán A, Carbajo-García MC, et al.

    Reproductive biology and endocrinology : RB&E 2024; (22(1)):10 doi:10.1186/s12958-023-01182-7.

    PMID: 38195505
  55. 55

    Women's experiences of the diagnostic journey in uterine adenomyosis: a scoping review protocol.

    Taylor MA, Croudace TJ, McBride M, Muir FE

    BMJ open 2024; (14(1)):e075316 doi:10.1136/bmjopen-2023-075316.

    PMID: 38238180
  56. 56

    Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.

    Choudhury S, Jena SK, Mitra S, et al.

    Therapeutic advances in reproductive health 2024; (18()):26334941241227401 doi:10.1177/26334941241227401.

    PMID: 38283750
  57. 57

    The timing of adenomyosis diagnosis and its impact on pregnancy outcomes: a national population-based study.

    Jung YM, Wi W, Koo HS, et al.

    Obstetrics & gynecology science 2024; (67(3)):270-278 doi:10.5468/ogs.23273.

    PMID: 38404226
  58. 58

    Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding.

    Vannuccini S, Meleca C, Toscano F, et al.

    Reproductive biomedicine online 2024; (48(5)):103768 doi:10.1016/j.rbmo.2023.103768.

    PMID: 38432071
  59. 59

    Knowledge, attitudes, and practices among Chinese reproductive-age women toward uterine adenomyosis.

    Ren R, Li H, Zhang J, et al.

    Frontiers in medicine 2024; (11()):1361671 doi:10.3389/fmed.2024.1361671.

    PMID: 38651069
  60. 60

    Comparison of the effectiveness of levonorgestrel intrauterine system and dienogest in the management of adenomyosis: A systematic review and meta-analysis.

    Akhigbe RE, Afolabi OA, Adegbola CA, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2024; (300()):230-239 doi:10.1016/j.ejogrb.2024.07.038.

    PMID: 39032312
  61. 61

    Predicting disease recurrence in patients with endometriosis: an observational study.

    Holdsworth-Carson SJ, Chung J, Machalek DA, et al.

    BMC medicine 2024; (22(1)):320 doi:10.1186/s12916-024-03508-7.

    PMID: 39113136
  62. 62

    Adenomyosis-A Call for Awareness, Early Detection, and Effective Treatment Strategies: A Narrative Review.

    Kolovos G, Dedes I, Imboden S, Mueller M

    Healthcare (Basel, Switzerland) 2024; (12(16)) doi:10.3390/healthcare12161641.

    PMID: 39201199
  63. 63

    Recommendations for the implementation and conduct of multidisciplinary team meetings for those providing endometriosis and adenomyosis care - a Delphi consensus of the European Endometriosis League (EEL).

    Burla L, Kalaitzopoulos DR, Samartzis N, et al.

    Facts, views & vision in ObGyn 2024; (16(3)):337-350 doi:10.52054/FVVO.16.3.038.

    PMID: 39357865
  64. 64

    Enhancing endometriosis care with telehealth: Opportunities and challenges.

    Perelmuter S, Shin JH

    Journal of telemedicine and telecare 2025; (31(10)):1413-1417 doi:10.1177/1357633X241287969.

    PMID: 39410856
  65. 65

    High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects.

    Bahutair SN, Alhubaishi LY

    Women's health (London, England) 2024; (20()):17455057241295593 doi:10.1177/17455057241295593.

    PMID: 39494764
  66. 66

    Progress in High Intensity Focused Ultrasound Ablation for Fertility Preservation Therapy of Uterine Fibroids and Adenomyosis.

    Zhang G, Li L, Sun M, Yu X

    Reproductive sciences (Thousand Oaks, Calif.) 2025; (32(1)):15-25 doi:10.1007/s43032-024-01745-y.

    PMID: 39532767
  67. 67

    Decreased expression of Syndecan- 1 (CD138) in the endometrium of adenomyosis patients suggests a potential pathogenetic role.

    Shaalan W, Ibrahim MG, Plasger A, et al.

    Acta obstetricia et gynecologica Scandinavica 2025; (104(1)):77-85 doi:10.1111/aogs.15012.

    PMID: 39568121
  68. 68

    Recurrence rates and associated risk factors after conservative surgery for adenomyosis: a retrospective study.

    Lu K, Zhong G, Lian B, et al.

    BMC women's health 2024; (24(1)):619 doi:10.1186/s12905-024-03457-6.

    PMID: 39578802
  69. 69

    Adenomyosis Localized in Both the Anterior and Posterior Myometrium Is Associated with Deep Rectal Endometriosis: A Retrospective Study.

    Schawlochow K, Samartzis N, Burla L, et al.

    Biomedicines 2024; (12(11)) doi:10.3390/biomedicines12112527.

    PMID: 39595092
  70. 70

    Effects of pretreatment strategies on fertility outcomes in patients with adenomyosis.

    Moawad G, Youssef Y, Fruscalzo A, et al.

    Frontiers in reproductive health 2024; (6()):1484202 doi:10.3389/frph.2024.1484202.

    PMID: 39717429
  71. 71

    Women's experiences of living with adenomyosis and perceptions of the diagnostic journey: a scoping review.

    Taylor MA, Croudace TJ, Muir FE, McBride M

    BMJ open 2025; (15(1)):e087122 doi:10.1136/bmjopen-2024-087122.

    PMID: 39832979
  72. 72

    Hormone receptor profile of ectopic and eutopic endometrium in adenomyosis: a systematic review.

    Maclean A, Tipple L, Newton E, Hapangama DK

    Human reproduction open 2025; (2025(1)):hoaf002 doi:10.1093/hropen/hoaf002.

    PMID: 39935764
  73. 73

    Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society.

    Lin CW, Ou HT, Wu MH, et al.

    Gynecology and minimally invasive therapy 2025; (14(1)):24-32 doi:10.4103/gmit.GMIT-D-24-00055.

    PMID: 40143988
  74. 74

    Reduced live birth rates following ART in adenomyosis patients: a matched control study.

    Bourdon M, Mimouni A, Maignien C, et al.

    Human reproduction (Oxford, England) 2025; (40(5)):855-864 doi:10.1093/humrep/deaf052.

    PMID: 40159349
  75. 75

    Adenomyosis: the missed disease.

    Santulli P, Vannuccini S, Bourdon M, et al.

    Reproductive biomedicine online 2025; (50(4)):104837 doi:10.1016/j.rbmo.2025.104837.

    PMID: 40287215
  76. 76

    Imaging Spectrum of Typical and Atypical Adenomyosis.

    Brandão A, Oliveira BC, Ferreira IAG, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(5)):e240152 doi:10.1148/rg.240152.

    PMID: 40310751
  77. 77

    Diagnosing adenomyosis using transvaginal ultrasound in current practice: A scoping review and service evaluation.

    Smith D, Bolton G

    Ultrasound (Leeds, England) 2026; (34(2)):129-138 doi:10.1177/1742271X251338147.

    PMID: 40357226
  78. 78

    Assessing the impact of a regional multidisciplinary team meeting for endometriosis using the CovotemⓇ online platform.

    Caroff A, Scheffler F, Bulle C, et al.

    Journal of gynecology obstetrics and human reproduction 2025; (54(7)):102978 doi:10.1016/j.jogoh.2025.102978.

    PMID: 40383261
  79. 79

    The etiology differs regards to the locations of the lesion: a clinical experience of 1350 patients with adenomyosis confirmed by postoperative pathology.

    Li W, Hang Y, Xu Y, et al.

    BMC women's health 2025; (25(1)):268 doi:10.1186/s12905-025-03759-3.

    PMID: 40448071
  80. 80

    The downregulation of FKBP5 contributes to the pathogenesis of adenomyosis and is associated with impaired endometrial receptivity†.

    Wang M, Xiang Y, Zhang D, et al.

    Biology of reproduction 2025; (113(4)):794-802 doi:10.1093/biolre/ioaf126.

    PMID: 40518930
  81. 81

    Association between pre-pregnancy uterine volume and preterm birth in women with adenomyosis: a retrospective cohort study.

    Guan X, Liu D, Zhou H, et al.

    BMC pregnancy and childbirth 2025; (25(1)):718 doi:10.1186/s12884-025-07845-0.

    PMID: 40610904
  82. 82

    Maternal and Neonatal Outcomes in Pregnancies with Adenomyosis.

    Hguig S, Czuzoj-Shulman N, Spence AR, Abenhaim HA

    Maternal and child health journal 2025; (29(9)):1284-1292 doi:10.1007/s10995-025-04138-y.

    PMID: 40634714
  83. 83

    High-Intensity Focused Ultrasound (HIFU) in Pancreatic Cancer-Related Pain: Current Evidence and Future Directions.

    Liu Y, Chen M, Liu L, et al.

    Ultrasound in medicine & biology 2025; (51(10)):1639-1645 doi:10.1016/j.ultrasmedbio.2025.05.032.

    PMID: 40670261
  84. 84

    Exploring Salvia miltiorrhiza's Therapeutic Effects on Adenomyosis by Inhibiting TNF-α/HIF-1α/IL-17-Driven Inflammatory Cascade: Mechanistic Insights from Target Prediction and Experimental Validation.

    Yang Q, Hong J, Zheng X, et al.

    Journal of inflammation research 2025; (18()):11551-11575 doi:10.2147/JIR.S537221.

    PMID: 40873782
  85. 85

    Clinical value of hysteroscopic levonorgestrel intrauterine system suture fixation in treating adenomyosis.

    Wang J, Gong L, Xin Y, et al.

    BMC women's health 2025; (25(1)):482 doi:10.1186/s12905-025-04040-3.

    PMID: 41068725
  86. 86

    Systemic comorbidities in patients with adenomyosis.

    Gallone A, Vannuccini S, Manzi V, et al.

    Reproductive biomedicine online 2025; (51(6)):105102 doi:10.1016/j.rbmo.2025.105102.

    PMID: 41176881
  87. 87

    The Pumpkin method - An innovative uterus-preserving surgery for large complex adenomyosis: A preliminary experience.

    Kung CH, Leung-Chit Tsang L, Chen WH, et al.

    Taiwanese journal of obstetrics & gynecology 2025; (64(6)):1009-1016 doi:10.1016/j.tjog.2025.07.024.

    PMID: 41213746
  88. 88

    Uterus-preserving surgery for diffuse adenomyosis via transumbilical single-port laparoscopy: combining dual-flap reconstruction and temporary uterine artery occlusion.

    Cao Y, Tian J, Liu X, Nie J

    Fertility and sterility 2026; (125(3)):536-539 doi:10.1016/j.fertnstert.2025.12.014.

    PMID: 41443365
  89. 89

    Pregnancy and perinatal outcomes in women with different phenotypes of adenomyosis: A retrospective cohort study.

    Yang W, Liu X, Zeng L, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2026; (318()):114926 doi:10.1016/j.ejogrb.2025.114926.

    PMID: 41483612
  90. 90

    Factors associated with hysterectomy after failure of levonorgestrel-releasing intrauterine system treatment in women with abnormal uterine bleeding.

    Erkal N, Kaba M, Erdoğan K, et al.

    BMC women's health 2026; (26(1)).

    PMID: 41840553
  91. 91

    The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies.

    Li F, Wang HJ, Zhang Y, et al.

    Seminars in immunopathology 2026; (48(1)).

    PMID: 42258013
  92. 92

    Association between adenomyosis subtypes and concurrent endometrial lesions: a propensity score-matched retrospective study.

    Niu X, Wang Y, Zhai Y, et al.

    Frontiers in endocrinology 2026; (17()):1842535 doi:10.3389/fendo.2026.1842535.

    PMID: 42290849